Larson Financial Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.7K Hold
485
– – ﹤0.01% 2123
2026
Q2
$17.8K Buy
485
+241
+99% +$6.53K ﹤0.01% 2067
2026
Q1
$4.39K Buy
244
+104
+74% +$2.08K ﹤0.01% 2665
2025
Q4
$3.28K Hold
140
– – ﹤0.01% 2635
2025
Q3
$2.79K Buy
+140
New +$2.51K ﹤0.01% 2576

Other funds holding URGN

Larson Financial Group's URGN Position: Q3 2026 in Review

Larson Financial Group held its UroGen Pharma (URGN) position steady in Q3 2026 at 485 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2123.

Larson Financial Group first reported a position in URGN in Q3 2025 and has held it in 5 quarters since. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.

  • Larson Financial Group held 485 shares of UroGen Pharma worth $19.7K as of Q3 2026.
  • Larson Financial Group left its UroGen Pharma share count unchanged in Q3 2026.
  • UroGen Pharma made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2123 holding.
  • Larson Financial Group first reported a position in UroGen Pharma in Q3 2025 and has held it in 5 quarters since.
  • 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.